Skip to main content
    P

    Purple Biotech (PPBT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.71
    +0.03 (+1.79%)

    Market Cap: $2.65M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Purple Biotech (PPBT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Purple Biotech (PPBT) has a market cap of $2.65M. Its share count is up 296.93% from a year earlier. It holds $5.10M more cash than debt, 192.40% of its market cap.

    Total Valuation

    Market Cap$2.65M
    Latest price (Nov 17, 2026)$1.71

    Key Dates

    Last Earnings DateAug 7, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 16.70% in the quarter ended Jun 30, 2026.

    Shares Outstanding10.86M
    Shares Change (YoY)+296.93%
    Shares Change (QoQ)+16.70%

    Valuation Ratios

    P/B Ratio1.5x
    P/TBV Ratio3.8x

    Price Statistics

    The stock is down 76.19% over 52 weeks and trades 23.02% above its 50-day average.

    Beta (1Y)0.08
    52-Week Change-76.19%
    1-Month Change+58.33%
    3-Month Change+7.55%
    6-Month Change-51.28%
    5-Year Change-99.86%
    10-Year Change-99.98%
    Total Return (1Y)-76.19%
    Total Return (3Y CAGR)-79.54%
    Total Return (5Y CAGR)-71.00%
    Return vs SPY (1Y)-90.21%
    Max Drawdown (1Y)-89.43%
    Max Drawdown (3Y)-99.58%
    Sharpe Ratio (1Y)-1.57
    Correlation with SPY (1Y)0.01
    50-Day Average$1.39
    200-Day Average$2.72
    52-Week Range$0.91 to $8.90
    RSI (14 Days)72.8
    Average Volume (20 Days)30.95K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.70x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio3.70x
    Quick Ratio3.70x
    Debt / Equity0.01x
    Interest Coverage-360.69x

    Returns and Efficiency

    Return on invested capital is -156.20% over the last 12 months, against a 5-year average of -71.63%.

    Return on Equity (ROE)-199.60%
    Return on Assets (ROA)-172.90%
    Return on Invested Capital (ROIC)-156.20%
    Return on Capital Employed (ROCE)-198.07%
    ROE (5Y Average)-85.27%
    ROA (5Y Average)-56.09%
    ROIC (5Y Average)-71.63%

    Scores

    PPBT has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$28.36M
    Pretax Income-$24.59M
    Net Income-$24.49M
    EBITDA-$24.28M
    EBIT-$24.53M
    Reported EPS (TTM)-$4.52

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 86.59% of the $14.17M in total assets.

    Cash and Equivalents$5.24M
    Total Debt$134.00K
    Net Cash$5.10M
    Working Capital$4.81M
    Shareholder Equity$12.27M
    Tangible Book Value$4.91M
    Total Assets$14.17M
    Total Liabilities$1.95M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.05M of capital spending, operating cash flow left -$9.81M of free cash flow.

    Operating Cash Flow-$7.76M
    Capital Expenditures$2.05M
    Free Cash Flow-$9.81M
    FCF Per Share-$6.03
    Depreciation and Amortization$246.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Stock Splits

    The last split was a 1-for-10 reverse split on Mar 2, 2026.

    Last Split DateMar 2, 2026
    Split TypeReverse split
    Split Ratio1:10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PPBT

    What is PPBT's market cap?

    Purple Biotech has a market cap of $2.65M.

    How many shares of PPBT are outstanding?

    Purple Biotech has 10.86M shares outstanding. The count is up 296.93% from a year earlier.

    Does PPBT pay a dividend?

    No. Purple Biotech does not pay a dividend.

    How much debt does PPBT have?

    Purple Biotech has $134.00K of total debt and $5.24M of cash and equivalents, a net cash position of $5.10M.